Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 22;22(4):397-405.
doi: 10.1093/ehjci/jeaa351.

Cardiac computed tomography in cardio-oncology: an update on recent clinical applications

Affiliations
Review

Cardiac computed tomography in cardio-oncology: an update on recent clinical applications

Stefania Rosmini et al. Eur Heart J Cardiovasc Imaging. .

Abstract

Chemotherapy and radiotherapy have drastically improved cancer survival, but they can result in significant short- and long-term cardiovascular complications, most commonly heart failure from chemotherapy, whilst radiotherapy increases the risk of premature coronary artery disease (CAD), valve, and pericardial diseases. Cardiac computed tomography (CT) with calcium scoring has a role in screening asymptomatic patients for premature CAD, cardiac CT angiography (CTCA) allows the identification of significant CAD, also in the acute settings where concerns exist towards invasive angiography. CTCA integrates the diagnostic work-up and guides surgical/percutaneous management of valvular heart diseases and allows the assessment of pericardial conditions, including detection of effusion and pericardial calcification. It is a widely available and fast imaging modality that allows a one-step evaluation of CAD, myocardial, valvular, and pericardial disease. This review aims to provide an update on its current use and accompanying evidence-base for cardiac CT in the management of cardio-oncology patients.

Keywords: cardiac CT; cardio-oncology; coronary artery disease; pericardial disease; valvular disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Different roles of Cardiac CT in screening, diagnosis, and management in cancer patients.
Figure 2
Figure 2
Coronary, valvular, and pericardial disease in Hodgkin lymphoma survivor treated with chemo and radiotherapy.
Figure 3
Figure 3
Radiation-induced valvular heart disease.
Figure 4
Figure 4
Chemotherapy-induced pericardial disease.

References

    1. Chung R, Ghosh AK, Banerjee A. Cardiotoxicity: precision medicine with imprecise definitions. Open Heart 2018;5:e000774. - PMC - PubMed
    1. Celutkiene J, Pudil R, Lopez-Fernandez T, Grapsa J, Nihoyannopoulos P, Bergler-Klein J et al. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC). Eur J Heart Fail 2020;22:1504–24. - PubMed
    1. Achenbach S, Marwan M, Ropers D, Schepis T, Pflederer T, Anders K et al. Coronary computed tomography angiography with a consistent dose below 1 mSv using prospectively electrocardiogram-triggered high-pitch spiral acquisition. Eur Heart J 2010;31:340–6. - PubMed
    1. Biersmith MA, Tong MS, Guha A, Simonetti OP, Addison D. Multimodality cardiac imaging in the era of emerging cancer therapies. J Am Heart Assoc 2020;9:e013755. - PMC - PubMed
    1. Williams MC, Stewart C, Weir NW, Newby DE. Using radiation safely in cardiology: what imagers need to know. Heart 2019;105:798–806. - PMC - PubMed

MeSH terms